Cefepime FDA Link Generic

A fourth-generation cephalosporin antibacterial agent that is used in the treatment of infections, including those of the abdomen, urinary tract, respiratory tract, and skin. It is effective against PSEUDOMONAS AERUGINOSA and may also be used in the empiric treatment of FEBRILE NEUTROPENIA.

Also Known As:

Maxipime; Axépim; BMY 28142; BMY-28142; Cefepim; Cefepime Hydrochloride; Quadrocef; BMY28142; Pyrrolidinium, 1- ((7- (((2- amino- 4- thiazolyl)(methoxyimino)acetyl)amino)- 2- carboxy- 8- oxo- 5- thia- 1- azabicyclo(4.2.0)oct- 2- en- 3- yl)methyl)- 1- methyl- , hydroxide, inner salt, (6R-(6alpha,7beta(Z)))-

Organic Chemicals: 140
- Amides: 2487
  - Lactams: 2278
    - beta-Lactams: 2435
      - Cephalosporins: 4066
        Cefepime: 1141
- Sulfur Compounds: 283
  - Thiazines: 3
    - Cephalosporins: 4066
      - Cefepime: 1141
Heterocyclic Compounds: 207
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - beta-Lactams: 2435
      - Cephalosporins: 4066
        Cefepime: 1141

P Koeppe Selected Research

P Koeppe Research Topics

Disease

Drug/Important Bio-Agent (IBA)